Search

everythinglearnresearchcommunity

for

Search:↓

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

The research shows that a gene called Wnt3 affects hair growth and structure, causing short hair and balding when overactive.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Early hair graying is often inherited and influenced by genetics, environment, and lifestyle, but treatment options are limited.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Treating hair loss in both men and women is effective and improves quality of life.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

No genetic link between prostaglandins and hair loss found.

A plant mixture extract helped grow hair by boosting cell growth and growth factors while blocking a hair loss-related enzyme.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The guide helps doctors diagnose hair problems by suggesting a thorough patient history, physical exams, and various diagnostic tools.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Melatonin improved cashmere production in goats during the first cycle but had no lasting effects on the next cycle.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.